Through the Pacific Networked Diagnostics and Support project (PaNDAS), CSIRO’s Australian Centre for Disease Preparedness (ACDP) is working with laboratories and field partners in Pacific Island countries and territories to strengthen Pacific capabilities to detect and diagnose animal and zoonotic diseases in the region.

CSIRO's Australian Centre for Disease Preparedness (ACDP) is supporting Southeast Asian and Pacific laboratories to adopt modern animal health diagnostic and surveillance tools through the APPLLe project.

CSIRO’s Australian Centre for Disease Preparedness (ACDP) is working with laboratories and field partners in Cambodia, Indonesia, Laos and the Philippines to strengthen capabilities to detect and diagnose emerging infectious diseases at the wildlife-livestock interface.

CSIRO’s Australian Centre for Disease Preparedness (ACDP) is providing targeted biorisk management training to laboratory leaders across Southeast Asia and the Pacific.

Australia is supporting the second phase of the Sydney Asia-Pacific Partnership for Health Innovations and Resilient Ecosystems (SAPPHIRE) to expand beyond Fiji, Kiribati and Vietnam and into Cambodia. In partnership with the University of Sydney, SAPPHIRE emphasises community participation, infectious and chronic disease control, health system strengthening, One Health adoption, climate change adaptation, and GEDSI integration for regional health security.

Through a collaboration with Indonesia’s Ministry of Agriculture, CSIRO’s Australian Centre for Disease Preparedness (ACDP) is supporting Indonesia’s Disease Investigation Centre Wates (DIC Wates) to strengthen its national role in identifying and characterising avian influenza outbreaks across Indonesia.

In partnership with three Thai state-owned organisations, CSIRO’s Biomedical Manufacturing team is improving Thailand’s capacity to manufacture essential drugs and improve local and equitable access to medicines.

CSIRO’s Biomedical Manufacturing team has partnered with the Malaysia Genome and Vaccine Institute (MGVI-NIBM) to build MGVI’s capability to manufacture vaccines, including a Leptospirosis vaccine.

Australia is supporting partner countries to build capacity for health systems to anticipate, prevent, detect and control priority disease threats through the Regional Engagement in Surveillance and response to Priority diseases, providing Opportunities for National health system strengthening and Development (RESPOND) partnership with Menzies School of Health Research. 

Australia is strengthening its commitment to the prevention, surveillance and response to infectious diseases across the Indo-Pacific through a strategic partnership with the Doherty Institute. Over the next four years, our partnership will focus on workforce development, policy support, and systems strengthening, and will specifically target laboratory strengthening, genomic surveillance, antimicrobial resistance (AMR), and data for decision making.